Literature DB >> 10375617

Isolation and characterization of genomic sequences involved in the regulation of the human reduced folate carrier gene (RFC1).

M Gong1, K H Cowan, J Gudas, J A Moscow.   

Abstract

Decreased reduced folate carrier (RFC) activity has been associated with MTX resistance in experimental models of transport-mediated MTX resistance, and has been attributed to changes in the expression of RFC1, the gene that encodes a protein with this activity. RNA transcripts of RFC1 may contain any one of four distinct 5' untranslated regions (UTRs). We cloned a human genomic DNA fragment upstream from the RFC1 translation start site and determined the nucleotide sequence of a 4.8kb region that contained the exons corresponding to each of the reported UTRs. To identify regulatory elements that may be involved in RFC1 transcription, we first developed a semi-quantitative RT-PCR assay using primers specific for each of the 5' UTRs to amplify RNA transcripts containing each of the RFC1 5' exons, and found evidence for differential transcription of RFC1 non-coding exons in tissues, during development, and in MTX-resistant, transport-deficient cells. We also found that RFC1 RNA levels are cell cycle regulated and peak at the G1 to S transition. Then, using a series of RFC1 promoter-reporter fusion constructs, we identified genomic sequences that may be involved in the regulation of expression of exons 1b and 1c of the RFC1 gene. These studies therefore identify regulatory regions of RFC1 promoters and potential models of regulation in which these regions may exert control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10375617     DOI: 10.1016/s0378-1119(99)00166-3

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  8 in total

1.  The human reduced folate carrier gene is ubiquitously and differentially expressed in normal human tissues: identification of seven non-coding exons and characterization of a novel promoter.

Authors:  Johnathan R Whetstine; Robin M Flatley; Larry H Matherly
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

Review 2.  SLC19: the folate/thiamine transporter family.

Authors:  Vadivel Ganapathy; Sylvia B Smith; Puttur D Prasad
Journal:  Pflugers Arch       Date:  2003-05-06       Impact factor: 3.657

3.  Compensatory evolution in rifampin-resistant Escherichia coli.

Authors:  M G Reynolds
Journal:  Genetics       Date:  2000-12       Impact factor: 4.562

4.  Polymorphisms and methylation of the reduced folate carrier in osteosarcoma.

Authors:  Rui Yang; Jing Qin; Bang H Hoang; John H Healey; Richard Gorlick
Journal:  Clin Orthop Relat Res       Date:  2008-06-05       Impact factor: 4.176

5.  Analysis of the MTHFD1 promoter and risk of neural tube defects.

Authors:  Nicola Carroll; Faith Pangilinan; Anne M Molloy; James Troendle; James L Mills; Peadar N Kirke; Lawrence C Brody; John M Scott; Anne Parle-McDermott
Journal:  Hum Genet       Date:  2009-01-08       Impact factor: 4.132

6.  Heterogeneous response of different tumor cell lines to methotrexate-coupled nanoparticles in presence of hyperthermia.

Authors:  Marcus Stapf; Nadine Pömpner; Ulf Teichgräber; Ingrid Hilger
Journal:  Int J Nanomedicine       Date:  2016-02-04

7.  The study of association between reduced folate carrier 1 (RFC1) polymorphism and non-syndromic cleft lip/palate in Iranian population.

Authors:  Behnoosh Soghani; Asghar Ebadifar; Hamid Reza Khorram Khorshid; Koorosh Kamali; Roya Hamedi; Fatemeh Aghakhani Moghadam
Journal:  Bioimpacts       Date:  2017-11-28

8.  Quantitative correlation between promoter methylation and messenger RNA levels of the reduced folate carrier.

Authors:  Rui Yang; Wei-Wei Li; Bang H Hoang; Hansoo Kim; Debabrata Banerjee; Albert Kheradpour; John H Healey; Paul A Meyers; Joseph R Bertino; Richard Gorlick
Journal:  BMC Cancer       Date:  2008-05-01       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.